CA2501846A1 - Combinaisons therapeutiques pour le traitement des carences hormonales - Google Patents

Combinaisons therapeutiques pour le traitement des carences hormonales Download PDF

Info

Publication number
CA2501846A1
CA2501846A1 CA002501846A CA2501846A CA2501846A1 CA 2501846 A1 CA2501846 A1 CA 2501846A1 CA 002501846 A CA002501846 A CA 002501846A CA 2501846 A CA2501846 A CA 2501846A CA 2501846 A1 CA2501846 A1 CA 2501846A1
Authority
CA
Canada
Prior art keywords
testosterone
steroid
binding globulin
sex hormone
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002501846A
Other languages
English (en)
Inventor
Roland Gerritsen Van Der Hoop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Products LLC
Original Assignee
Solvay Pharmaceuticals, Inc.
Roland Gerritsen Van Der Hoop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals, Inc., Roland Gerritsen Van Der Hoop filed Critical Solvay Pharmaceuticals, Inc.
Priority claimed from CA002451725A external-priority patent/CA2451725C/fr
Publication of CA2501846A1 publication Critical patent/CA2501846A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002501846A 2002-06-26 2002-06-26 Combinaisons therapeutiques pour le traitement des carences hormonales Abandoned CA2501846A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2,451,725 2002-06-26
CA002451725A CA2451725C (fr) 2001-06-27 2002-06-26 Combinaisons therapeutiques pour le traitement des carences hormonales

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002451725A Division CA2451725C (fr) 2001-06-27 2002-06-26 Combinaisons therapeutiques pour le traitement des carences hormonales

Publications (1)

Publication Number Publication Date
CA2501846A1 true CA2501846A1 (fr) 2003-01-09

Family

ID=34596863

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002501846A Abandoned CA2501846A1 (fr) 2002-06-26 2002-06-26 Combinaisons therapeutiques pour le traitement des carences hormonales

Country Status (1)

Country Link
CA (1) CA2501846A1 (fr)

Similar Documents

Publication Publication Date Title
CA2451725C (fr) Combinaisons therapeutiques pour le traitement des carences hormonales
US20150250801A1 (en) Androgen pharmaceutical composition and method for treating depression
EP1315502B1 (fr) Methode pour traiter la dyserection et augmenter la libido chez l'homme
US20050049233A1 (en) Method for treating erectile dysfunction and increasing libido in men
US20050152956A1 (en) Method of increasing testosterone and related steroid concentrations in women
CA2419573C (fr) Procede pour augmenter la concentration de testosterone et de steroides apparentes chez la femme
US20070154533A1 (en) Method of increasing testosterone and related steriod concentrations in women
US20110306582A1 (en) Androgen pharmaceutical composition and method for treating depression
AU2001285367A1 (en) Method of increasing testosterone and related steroid concentrations in women
AU2003228314B8 (en) Androgen pharmaceutical composition and method for treating depression
CA2501846A1 (fr) Combinaisons therapeutiques pour le traitement des carences hormonales
RU2286787C2 (ru) Способ повышения концентрации тестостерона и родственных стероидов у женщин
CA2498267C (fr) Methode pour traiter la dyserection et augmenter la libido chez l'homme
CA2497686A1 (fr) Procede pour augmenter la concentration de testosterone et de steroides apparentes chez la femme

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20130318